
Cleveland BioLabs, Inc. CBLI
Cleveland BioLabs, Inc. ROE Ratio | CBLI
Annual ROE Ratio Cleveland BioLabs, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -119.12 | -268.92 | -99.94 | -131.02 | -20.7 | -84.04 | 91.21 | -1091.91 | -89.01 | -18.04 |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.21 | -1091.91 | -183.15 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Curis
CRIS
|
-138.81 | $ 0.88 | 3.67 % | $ 11.6 M | ||
|
Cyclerion Therapeutics
CYCN
|
-46.78 | $ 34.99 | 3.77 % | $ 147 M | ||
|
Завод ДИОД
DIOD
|
3.1 | - | - | - | ||
|
CorMedix
CRMD
|
40.23 | $ 5.31 | 1.43 % | $ 383 K | ||
|
Novartis AG
NVS
|
30.0 | $ 162.64 | 0.44 % | $ 315 B | ||
|
CRISPR Therapeutics AG
CRSP
|
-30.26 | $ 50.09 | 3.15 % | $ 4.5 B | ||
|
PDS Biotechnology Corporation
PDSB
|
-81.75 | $ 1.22 | 4.27 % | $ 56.6 M | ||
|
Pfizer
PFE
|
8.99 | $ 29.39 | -0.22 % | $ 167 B | ||
|
Pharming Group N.V.
PHAR
|
22.12 | $ 12.32 | 0.16 % | $ 8.49 B | ||
|
Orgenesis
ORGS
|
128.44 | - | -33.86 % | $ 61.2 M | ||
|
Cytokinetics, Incorporated
CYTK
|
119.0 | $ 53.74 | -3.26 % | $ 6.45 M | ||
|
Фармсинтез
LIFE
|
-51.75 | - | - | - | ||
|
Prothena Corporation plc
PRTA
|
-87.03 | $ 7.93 | 0.51 % | $ 427 M | ||
|
Codiak BioSciences
CDAK
|
-69.45 | - | -55.98 % | $ 2.15 M | ||
|
DBV Technologies S.A.
DBVT
|
-87.07 | $ 10.54 | 7.55 % | $ 1.47 B | ||
|
Rocket Pharmaceuticals
RCKT
|
-80.49 | $ 2.38 | -2.05 % | $ 264 M | ||
|
Regeneron Pharmaceuticals
REGN
|
14.41 | $ 904.69 | 0.2 % | $ 94.6 B | ||
|
Replimune Group
REPL
|
-188.91 | $ 21.67 | 8.24 % | $ 2.01 B | ||
|
DiaMedica Therapeutics
DMAC
|
-58.39 | $ 9.47 | 4.76 % | $ 445 M | ||
|
Royalty Pharma plc
RPRX
|
7.94 | $ 67.31 | -0.39 % | $ 28.9 B | ||
|
Checkpoint Therapeutics
CKPT
|
445.47 | - | - | $ 169 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
-0.14 | $ 111.51 | 6.18 % | $ 7.25 B | ||
|
Puma Biotechnology
PBYI
|
23.87 | $ 8.28 | -15.25 % | $ 414 M | ||
|
SIGA Technologies
SIGA
|
11.71 | $ 3.12 | 4.55 % | $ 223 M | ||
|
Sage Therapeutics
SAGE
|
-86.15 | - | - | $ 527 M | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
1.47 | - | - | $ 1.62 B | ||
|
Sol-Gel Technologies Ltd.
SLGL
|
-26.86 | $ 61.62 | -2.21 % | $ 172 M | ||
|
SELLAS Life Sciences Group
SLS
|
-37.9 | $ 8.41 | 6.73 % | $ 917 M | ||
|
Summit Therapeutics
SMMT
|
-163.86 | $ 16.34 | 15.15 % | $ 12.2 B | ||
|
Cabaletta Bio
CABA
|
-149.81 | $ 1.3 | 1.17 % | $ 131 M | ||
|
Syndax Pharmaceuticals
SNDX
|
-441.62 | $ 9.53 | 1.39 % | $ 826 M | ||
|
Sanofi
SNY
|
10.95 | $ 47.06 | 0.32 % | $ 57.4 B | ||
|
Forma Therapeutics Holdings
FMTX
|
-34.71 | - | - | $ 958 M | ||
|
Blueprint Medicines Corporation
BPMC
|
-22.46 | - | - | $ 8.14 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
10.28 | - | - | $ 26.6 B | ||
|
Sarepta Therapeutics
SRPT
|
-62.55 | $ 17.8 | 0.68 % | $ 1.78 B | ||
|
Paratek Pharmaceuticals
PRTK
|
37.16 | - | - | $ 121 M | ||
|
China SXT Pharmaceuticals
SXTC
|
-20.89 | $ 2.84 | -3.07 % | $ 1.93 M | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
1.56 | $ 21.02 | -0.92 % | $ 33.2 B | ||
|
Tarsus Pharmaceuticals
TARS
|
-19.22 | $ 68.11 | 0.87 % | $ 2.85 B | ||
|
ASLAN Pharmaceuticals Limited
ASLN
|
332.81 | - | -14.27 % | $ 1.7 M | ||
|
Bio-Techne Corporation
TECH
|
8.63 | $ 72.78 | 0.17 % | $ 11.4 B | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
17.83 | $ 42.32 | 1.33 % | $ 48.5 B | ||
|
RedHill Biopharma Ltd.
RDHL
|
176.55 | $ 0.43 | 0.45 % | $ 5.3 B | ||
|
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | ||
|
Unity Biotechnology
UBX
|
-400.22 | - | -33.41 % | $ 3.37 M | ||
|
iTeos Therapeutics
ITOS
|
-22.77 | - | - | $ 411 M | ||
|
Shattuck Labs
STTK
|
-59.24 | $ 4.59 | 2.78 % | $ 319 M | ||
|
Seelos Therapeutics
SEEL
|
113.05 | - | -47.76 % | $ 6.27 M | ||
|
Evogene Ltd.
EVGN
|
-65.36 | $ 0.28 | -16.14 % | $ 2.2 M |